Home
Novasep

Novasep Market Share Analysis for August 2026

At Axplora, we honor ourselves on providing an extensive and diverse portfolio of small molecule Active Pharmaceutical Ingredients (APIs) that cater to the evolving needs of the pharmaceutical industry. As a prominent figure in the global pharmaceutical landscape, we have established ourselves as a leading manufacturer, specializing in both non-sterile and sterile steroids.

Science and Education > Environmental Science

Domainnovasep.com

Year Founded1993

Employees1001 - 5000

Annual Revenue$200M - $500M

Novasep

Novasep (including company regionals)

novasep.com

See more website traffic and engagement information

Novasep Revenue up to August 2026 is 200M - 500M

revenue generated by Novasep top domains

Novasep top domains revenue over 3 years

Revenue for Novasep top domains

novasep.com200M - 500M

See more with Sales Intelligence

Total visits to Novasep's top domains

Understand Novasep market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Novasep's top domains

Analyze Novasep engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Novasep's top domains

See how Novasep keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Novasep top competitors by domain

Top similar sites in August 2026, ranked by their affinity

dataflowsys.comCompany NameData Flow SystemsEmployees51 - 200HQUnited States, Florida, MelbourneAnnual revenue$15M - $25MTotal visits2.1KScience and Education > Environmental Science

Top technologies used by Novasep

These are the website technologies, by industry, used by Novasep top domains

Advertising (4)

DoubleClick

Audio Video Media (2)

YouTube

Email Services (2)

Microsoft Exchange Online

Marketing (2)

Google Marketing Platform

More Technologies

10

See all

News & Signals from Novasep

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNovasep invested into assets: API manufacturing site in France, Western Europe, Europe on Jun 1st '21.In June 2021, Novasep Holdings SAS (France) announced an investment of USD 6.9 million (EUR 6.1 million) to modernize and revamp the API manufacturing site in Mourenx, France.

NewsNovasep partnered with exelixis capital AG on Jul 1st '21.For instance, in July 2021, Novasep, provider of pharmaceutical and biopharmaceutical technologies, announced the signing of a manufacturing services agreement with Exelixis, a commercially successful, oncology-focused U.S. biotechnology company, for the cGMP clinical production of XB002, a next-generation tissue factor-targeting antibody-drug conjugate (ADC) for oncology applications.

NewsPharmaZell Group partnered with Novasep on Sep 1st '21.PharmaZell—a company that specializes in supplying specialty active pharmaceutical ingredients (APIs)—has announced the closing of its merger with Novasep, a contract development and manufacturing organization with expertise in complex small molecules and antibody-drug conjugates (ADCs).